Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription. Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription.
– Norbert Bischofberger, Ph.D., is stepping down from his role as President & CEO – – Deborah Knobelman, Ph.D., COO & CFO, is named President & Interim CEO – SAN MATEO, Calif. and...
– Preclinical data demonstrate the ability of p300 KAT inhibition to modulate multiple pro-inflammatory signaling pathways, including antibodies and cytokine production, in ex vivo and in vivo...
– Discontinuing development of istisociclib, a CDK9 inhibitor; benefit-risk profile in platinum-resistant high-grade serous ovarian cancer does not support further development – – Kronos Bio...
– Data demonstrates Kronos Bio's approach to targeting oncogenic transcription factors and the strong relationship between IRF4 and p300 in Multiple Myeloma – – Poster presentation to take place...
SAN MATEO, Calif., and CAMBRIDGE, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to developing small molecule therapeutics that address cancers and...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.05 | -4.71698113208 | 1.06 | 1.07 | 0.9885 | 241548 | 1.02898225 | CS |
| 4 | 0.0301 | 3.07174201449 | 0.9799 | 1.07 | 0.9165 | 211049 | 0.99889041 | CS |
| 12 | 0.1397 | 16.051936114 | 0.8703 | 1.09 | 0.8 | 321711 | 0.94759519 | CS |
| 26 | -0.27 | -21.09375 | 1.28 | 1.4 | 0.8 | 187261 | 0.96121236 | CS |
| 52 | -0.11 | -9.82142857143 | 1.12 | 1.6 | 0.69 | 291243 | 1.03571664 | CS |
| 156 | -8.12 | -88.9375684556 | 9.13 | 9.4 | 0.69 | 295332 | 2.37213348 | CS |
| 260 | -27.28 | -96.4298338636 | 28.29 | 39.605 | 0.69 | 280756 | 8.05600164 | CS |
| Symbol | Preis | Vol. |
|---|---|---|
| TCTMTCTM Kids IT Education Inc | US$ 0,764 (321,87%) | 729,72M |
| NVDANVIDIA Corporation | US$ 120,07 (-3,67%) | 388,54M |
| RIMEAlgorhythm Holdings Inc | US$ 0,02565 (5,12%) | 338,75M |
| BHATBlue Hat Interactive Entertainment Technology | US$ 0,0355 (-11,25%) | 236,29M |
| CLEUChina Liberal Education Holdings Ltd | US$ 0,1938 (30,77%) | 234,8M |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
